Carregant...
Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects
Bcr-Abl acquires its transforming abilitythro ugh its upregulated Abl tyrosine kinase activity. Bcr is a phosphoprotein with a novel serine/threonine kinase activitye ncoded by its first exon. In chronic myelogenous leukemia (CML) cells, Bcr-Abl phosphorylates Bcr on tyrosine residues reducing its k...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2585769/ https://ncbi.nlm.nih.gov/pubmed/17934518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.onc.1210851 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|